Literature DB >> 20044371

Implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry system.

Lauren McCluggage1, Kimberly Lee, Teresa Potter, Richard Dugger, Amy Pakyz.   

Abstract

PURPOSE: The implementation and evaluation of vancomycin nomogram guidelines in a computerized prescriber-order-entry (CPOE) system are described.
METHODS: Initial vancomycin orders for patients over age 18 years who received vancomycin between August 1 and September 30, 2006 (preimplementation), and between March 1 and April 30, 2007 (postimplementation), were compared with vancomycin nomogram recommendations to determine if the vancomycin regimen ordered coincided with the nomogram recommendation. The numbers of regimen changes and vancomycin serum concentrations measured during the first five days of therapy were also assessed. A multivariate logistic regression model assessed independent predictors of an initial vancomycin order that met the nomogram recommendation
RESULTS: A total of 522 vancomycin orders were included in the analysis (279 in the preimplementation group and 243 in the postimplementation group). A significant difference was observed in the percentage of initial vancomycin orders that met nomogram recommendations in the postimplementation group compared with the preimplementation group (36% versus 24%, p = 0.0028). No difference was noted between the two groups in the number of regimen changes or serum vancomycin concentrations measured during the first five days of therapy. In a multivariate analysis, age (p = 0.02) and weight (p < 0.0001) were negatively associated with a vancomycin order that met nomogram recommendations, while the postimplementation group was positively associated with an order that met nomogram recommendations (p = 0.001).
CONCLUSION: A vancomycin nomogram implemented into a CPOE system increased the likelihood of patients receiving an initial vancomycin regimen that coincided with the nomogram's recommendations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20044371     DOI: 10.2146/ajhp080625

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Questioning the accuracy of trough concentrations as surrogates for area under the curve in determining vancomycin safety.

Authors:  Cameron J Phillips
Journal:  Ther Adv Drug Saf       Date:  2014-06

2.  Effects of clinical decision support on initial dosing and monitoring of tobramycin and amikacin.

Authors:  Zachary L Cox; Cori L Nelsen; Lemuel R Waitman; Jacob A McCoy; Josh F Peterson
Journal:  Am J Health Syst Pharm       Date:  2011-04-01       Impact factor: 2.637

3.  Optimization of time to initial vancomycin target trough improves clinical outcomes.

Authors:  Anthony P Cardile; Christopher Tan; Michael B Lustik; Amy N Stratton; Cristian S Madar; Jun Elegino; Günther Hsue
Journal:  Springerplus       Date:  2015-07-19

Review 4.  Interventions targeting the prescribing and monitoring of vancomycin for hospitalized patients: a systematic review with meta-analysis.

Authors:  Cameron J Phillips; Alice J Wisdom; Ross A McKinnon; Richard J Woodman; David L Gordon
Journal:  Infect Drug Resist       Date:  2018-10-31       Impact factor: 4.003

5.  Assessment of vancomycin utilization among Lebanese hospitals.

Authors:  Diana N Malaeb; Iqbal M Fahs; Pascale Salameh; Souheil Hallit; Manal Saad; Jassem Bourji; Rabih Hallit
Journal:  Saudi Med J       Date:  2019-02       Impact factor: 1.484

6.  A specially tailored vancomycin continuous infusion regimen for renally impaired critically ill patients.

Authors:  Eman Mohamed Bahgat Eldemiry; Nirmeen A Sabry; Maggie M Abbassi; Sanaa S Abdel Shafy; Mohamed S Mokhtar; Ahmed Abdel Bary
Journal:  SAGE Open Med       Date:  2013-10-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.